MGO One Seven LLC Sells 806 Shares of The Cigna Group (NYSE:CI)

MGO One Seven LLC reduced its stake in shares of The Cigna Group (NYSE:CI - Free Report) by 23.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,599 shares of the health services provider's stock after selling 806 shares during the quarter. MGO One Seven LLC's holdings in The Cigna Group were worth $718,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the stock. TCTC Holdings LLC acquired a new stake in The Cigna Group in the fourth quarter valued at about $25,000. Collier Financial bought a new stake in shares of The Cigna Group during the 4th quarter valued at approximately $32,000. ORG Wealth Partners LLC acquired a new position in The Cigna Group during the 4th quarter worth approximately $34,000. Compagnie Lombard Odier SCmA acquired a new position in shares of The Cigna Group during the fourth quarter worth $37,000. Finally, Transce3nd LLC acquired a new stake in shares of The Cigna Group during the 4th quarter valued at $38,000. Institutional investors own 86.99% of the company's stock.

Insider Transactions at The Cigna Group

In related news, insider Nicole S. Jones sold 4,904 shares of The Cigna Group stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $1,511,020.48. Following the sale, the insider now owns 29,421 shares of the company's stock, valued at approximately $9,065,198.52. The trade was a 14.29 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO David Cordani sold 26,527 shares of the stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $8,173,499.24. Following the transaction, the chief executive officer now directly owns 127,767 shares of the company's stock, valued at approximately $39,367,568.04. This trade represents a 17.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 43,751 shares of company stock worth $13,603,991 in the last 90 days. Insiders own 0.70% of the company's stock.

The Cigna Group Stock Down 1.2 %

Shares of NYSE CI traded down $3.89 during midday trading on Friday, hitting $331.29. 1,116,190 shares of the stock traded hands, compared to its average volume of 1,702,315. The Cigna Group has a one year low of $262.03 and a one year high of $370.83. The business has a 50 day moving average price of $322.82 and a two-hundred day moving average price of $310.34. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The company has a market cap of $90.67 billion, a PE ratio of 27.07, a P/E/G ratio of 0.98 and a beta of 0.51.

The Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.35 by $0.39. The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. The business had revenue of $65.45 billion during the quarter, compared to the consensus estimate of $60.39 billion. During the same quarter in the prior year, the company posted $6.47 earnings per share. The Cigna Group's revenue was up 14.4% compared to the same quarter last year. On average, equities analysts predict that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd will be given a dividend of $1.51 per share. The ex-dividend date of this dividend is Tuesday, June 3rd. This represents a $6.04 annualized dividend and a dividend yield of 1.82%. The Cigna Group's dividend payout ratio is currently 49.35%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on CI shares. Raymond James reiterated a "strong-buy" rating and issued a $360.00 target price (down from $415.00) on shares of The Cigna Group in a research report on Friday, January 31st. Guggenheim began coverage on shares of The Cigna Group in a research report on Wednesday, April 9th. They set a "buy" rating and a $384.00 target price on the stock. Wells Fargo & Company decreased their price target on shares of The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating for the company in a research report on Tuesday, February 4th. Morgan Stanley reduced their price objective on shares of The Cigna Group from $403.00 to $379.00 and set an "overweight" rating on the stock in a research note on Friday, January 31st. Finally, StockNews.com raised The Cigna Group from a "buy" rating to a "strong-buy" rating in a report on Tuesday, April 8th. Two research analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, The Cigna Group presently has an average rating of "Buy" and a consensus price target of $373.56.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.